BLOG

Fierce-Pharma

Grifols readies US, EU approval push for blood clot treatment after phase 3 success

Grifols is readying an approval run at U.S. and European regulators on the back of a phase 3 win for the Spanish plasma medicine producer’s concentrated form of a blood clotting factor.